Analytical decision model for sample size and effectiveness projections for use in planning a population-based randomized controlled trial of colorectal cancer screening

Journal of Evaluation in Clinical Practice

Volumn 17, Issue 1, 2011, Pages 123-129

  Chiu, Sherry Y H ^a,b,d   Malila, Nea ^a,b   Yen, Amy M F ^c,e   Anttila, Ahti ^b   Hakama, Matti ^a,b   Chen, H H ^a,c,e  

^a UNIVERSITY OF TAMPERE   (Finland)

^b FINNISH CANCER REGISTRY   (Finland)

^c Graduate Institute of Epidemiology   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

colorectal cancer; mortality reduction; natural history; randomized controlled trial; sample size; surrogate end point

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER MORPHOLOGY; CANCER SCREENING; CANCER SURVIVAL; CLINICAL DECISION MAKING; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; OCCULT BLOOD TEST; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SAMPLE SIZE; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

AGED; BIOLOGICAL MARKERS; COLORECTAL NEOPLASMS; DECISION SUPPORT TECHNIQUES; HUMANS; MARKOV CHAINS; MASS SCREENING; MIDDLE AGED; PLANNING TECHNIQUES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SAMPLE SIZE; TAIWAN;

EID: 78751672732     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2010.01378.x     Document Type: Article

References (15)

1. Hardcastle, J. D., Chamberlain, J. O., Robinson, M. H., Moss, S., Amar, S. S., Balfour, T. W., James, P. D., &, Mangham, C. M., (1996) Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet, 348, 1427-1477.
2. Kronborg, O., Fenger, C., Olsen, J., Jorgensen, O. D., &, Sondergaard, O., (1996) Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet, 348, 1467-1471.
3. Jorgensen, O. D., Kronborg, O., &, Fenger, C., (2002) A randomized study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut, 50, 29-32.
4. Scholefield, J. H., Moss, S., Sufi, F., Mangham, C. M., &, Hardcastle, J. D., (2002) Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomized controlled trial. Gut, 50, 840-844.
5. Breslow, N. E., &, Day, N. E., (1980) Statistical Methods in Cancer Research. Volume II: The Design and Analysis of Cohort Studies. Lyon: International Agency for Research on Cancer.
6. Etzioni, R. D., Connor, R. J., Prorok, P. C., &, Self, S. G., (1995) Design and analysis of cancer screening trials. Statistical Methods in Medical Research, 4, 3-17.
7. Malila, N., Anttila, A., &, Hakama, M., (2005) Colorectal cancer screening in Finland: details of the national screening programme implemented in autumn 2004. Journal of Medical Screening, 12, 28-32.
8. Malila, N., Oivanen, T., Malminiemi, O., &, Hakama, M., (2008) Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design. British Medical Journal, 337, a2261.
9. Whynes, D. K., on behalf of the Nottingham FOB Screening Trial (2004) Cost-effectiveness of screening for colorectal cancer: evidence from the Nottingham faecal occult blood trial. Journal of Medical Screening, 11, 11-15.
10. Day, N. E., (1985) Estimating the sensitivity of a screening test. Journal of Epidemiology and Community Health, 39, 364-366.
11. Finnish Cancer Registry (2005) Institute for statistical and epidemiological cancer research. Available at: http://www.cancerregistry.fi (last accessed September 2007).
12. Chen, T. H. H., Kuo, H. S., Yen, M. F., Lai, M. S., Tabar, L., &, Duffy, S. W., (2000) Estimation of sojourn time in chronic disease screening without data on interval cases. Biometrics, 56, 167-172.
13. Wong, J. M., Yen, M. F., Lai, M. S., Duffy, S. W., Smith, R. A., &, Chen, T. H. H., (2004) Progression rates of colorectal cancer by Dukes' stage in a high-risk group: analysis of selective colorectal cancer screening. Cancer Journal, 10, 160-169.
14. Chen, H. H., Prevost, T. C., &, Duffy, S. W., (1999) Evaluation of screening for nasopharyngeal carcinoma: trial design using Markov chain models. British Journal of Cancer, 79, 1894-1900.
15. Moss, S., Draper, G. J., Hardcastle, J. D., &, Chamberlain, J., (1987) Calculation of sample size in trials of screening for early diagnosis of disease. International Journal of Epidemiology, 16, 104-110.